Healthcare
SANUWAVE Health, Inc.(SNWV)
Live Price
Offline$9.21
+1.32% today
1Y Change
-55.59%
Window
Jun 23, 2025 โ Jun 12, 2026
- Market Cap
- $140.00M
- Revenue Growth
- +35.0%
- EPS Growth
- +119.6%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 23, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
SANUWAVE Health, Inc. (SNWV) is a Healthcare stock with a market cap of $140.00M and listed on NASDAQ. The stock last traded around $9.21 and down 55.6% across the available one-year price window (Jun 23, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of +35.0%, EPS growth of +119.6%, a dividend yield of 0.0%. What stands out right now is revenue +35.0%, EPS +119.6%, free cash flow -1.6% with operating margin 11.2% and ROIC 19.4%. Valuation is more restrained than many high-expectation growth names at P/E 11.4 and price/sales 3.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SNWV price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+35.0% vs +7.6% peer median
Operating Margin
Below sector median
+11.2% vs +19.4% peer median
P/E
Below sector median
11.4 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 8, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +35.0% and EPS at +119.6%, with operating margin around 11.2%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +1.3% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 8, 2026 | โ | +2.8% | +8.2% | -6.6% |
2026 Mar 26, 2026 | -82.3% | -1.3% | -10.3% | -0.8% |
2025 Nov 7, 2025 | +43.8% | +10.2% | +6.1% | -3.9% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SNWV
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SNWV Max Drawdown
-68.04%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SNWV and SPY.
Company Overview
SANUWAVE Health, Inc.
NASDAQ Global Market
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.
- Leadership
- Morgan C. Frank
- IPO Date
- Sep 30, 2009
- Employees
- 46
- Street Address
- 3360 Martin Farm Road
- Mailing
- Suwanee, GA, 30024
- Region
- Suwanee, GA, US
- Reporting Currency
- USD
- Investor Line
- 770 419 7525
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 11.4
- EV/EBITDA
- 23.5
- Price/Sales
- 3.1
- Price/Book
- 83.2
Growth
- Revenue
- +35.0%
- EPS
- +119.6%
- Free Cash Flow
- -1.6%
Profitability
- Gross Margin
- 75.1%
- Operating Margin
- 11.2%
- Net Margin
- 26.8%
- ROE
- -141.6%
- ROIC
- 19.4%
Balance Sheet
- Debt/Equity
- 14.19
- Current Ratio
- 1.38
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.